Table 2.
N | Type II | Type II+III | Type III | ||||
---|---|---|---|---|---|---|---|
No. | (%) | No. | (%) | No. | (%) | ||
Sporadic CH | 37 | 24 | (64.8%) | - | - | 13 | (35.2%) |
HCC | 6 | 6 | (100.0%) | - | - | - | - |
PT-NANBH | 9 | 9 | (100.0%) | - | - | - | - |
Blood Donor | 4 | 3 | (75.0%) | - | - | 1 | (25.0%) |
| |||||||
Total No. | 56 | 42 | (75.0%) | - | - | 14 | (25.0%) |
CH: chronic hepatitis
HCC: hepatocellular carcinoma
PT-NANBH: post-transfusion non-A, non-B hepatitis